* CRISPR THERAPEUTICS SUBMITS FIRST CLINICAL TRIAL APPLICATION FOR A CRISPR GENE-EDITED THERAPY, CTX001 IN Β-THALASSEMIA


60


Reuters

Latest News

CNBC: Cantor's Cecchini: If the Fed doesn't raise rates today, that would send a very bad signal

CNBC: Warwick Energy CEO: US oil and gas companies can't like the prospect of lower oil prices in 2019

CNBC: Dow futures higher | Fed rate decision set | Pfizer, GSK agree to $12.7 billion deal

CNBC: Here's what happens next in the Huawei CFO case

ABC: Ukraine secures new IMF loan after making reforms

Haaretz: Netanyahu: Lebanon wasn't aware of Hezbollah tunnels, but should now 'neutralize them'

Haaretz: Trump turns the ties between Israel and U.S. Jews totally toxic

WashingtonPost: Falling Out: D.C. officials ignored life-saving strategies while African American heroin overdoses surged

WashingtonPost: Your ‘grass-fed’ beef may have not have come from a cow grazing in a pasture. Here’s why.

WashingtonPost: If 2018’s rains wrecked your garden, it might be time to try something new

WashingtonPost: The Patriots’ dynasty is fading. But they might have one more Super Bowl run left in them.

FOX: Former federal prosecutor reacts to Flynn's delayed sentence

FOX: Federal Reserve set to announce big interest rate hike

FOX: Louisville dance team coach fired for fiscal misconduct

FOX: 2018’s worst cosmetic surgery mishaps

FOX: 2018’s worst cosmetic surgery mishaps

Daily Mail: Is Solskjaer a good appointment as Man Utd interim manager?

BBC: Elusen yn gwrthod cyfraniad oherwydd 'lluniau sarhaus'

CNBC: Weekly mortgage applications drop 5.8% as stock market plunge unnerves potential buyers

Reuters: EU reaches deal over Italy budget, puts disciplinary steps on hold

Reuters: U.N. World Food Programme announces cutbacks in food assistance in Gaza, West Bank

Reuters: EU warns of border checks, end of licenses in no-deal Brexit

Reuters: British brewed Budweiser beer to rely on solar power from 2020